Abstract
Introduction
Sepsis is a heterogeneous syndrome that results in life-threatening organ dysfunction. Our goal was to determine the relevant variables and patient phenotypes to use in predicting sepsis outcomes.
Methods
We performed an ancillary study concerning 119 patients with septic shock at intensive care unit (ICU) admittance (T0). We defined clinical worsening as having an increased sequential organ failure assessment (SOFA) score of ≥ 1, 48 h after admission (ΔSOFA ≥ 1). We performed univariate and multivariate analyses based on the 28-day mortality rate and ΔSOFA ≥ 1 and determined three patient phenotypes: safe, intermediate and unsafe. The persistence of the intermediate and unsafe phenotypes after T0 was defined as a poor outcome.
Results
At T0, the multivariate analysis showed two variables associated with 28-day mortality rate: norepinephrine dose and serum lactate concentration. Regarding ΔSOFA ≥ 1, we identified three variables at T0: norepinephrine dose, lactate concentration and venous-to-arterial carbon dioxide difference (P(v-a)CO2). At T0, the three phenotypes (safe, intermediate and unsafe) were found in 28 (24%), 70 (59%) and 21 (18%) patients, respectively. We thus suggested using an algorithm featuring norepinephrine dose, lactate concentration and P(v-a)CO2 to predict patient outcomes and obtained an area under the curve (AUC) of 74% (63–85%).
Conclusion
Our findings highlight the fact that identifying relevant variables and phenotypes may help physicians predict patient outcomes.
Similar content being viewed by others
References
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762–74.
Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2015;193(3):259–72.
Gaieski D, Edwards J, Kallan M, Carr B. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–74.
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53.
Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795–815.
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–143.
Seymour CW, Rosengart MR. Septic shock: advances in diagnosis and treatment. JAMA. 2015;314(7):708–17.
Huang ACC, Lee TYT, Ko MC, et al. Fluid balance correlates with clinical course of multiple organ dysfunction syndrome and mortality in patients with septic shock. PLoS One. 2019;14(12):e0225423.
ARISE Investigators, ANZICS Clinical Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.
ProCESS Investigators, Yealy DM, Kellum JA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683–93.
Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372(14):1301–11.
Textoris J, Fouché L, Wiramus S, et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011;15(4):R176.
De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5(1):73–9.
Pope JV, Jones AE, Gaieski DF, et al. Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis. Ann Emerg Med. 2010;55(1):40-46.e1.
Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12(4):315–21.
Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med. 1997;25(1):58–62.
van Genderen ME, Klijn E, Lima A, et al. Microvascular perfusion as a target for fluid resuscitation in experimental circulatory shock. Crit Care Med. 2014;42(2):e96-105.
Bakker J, de Backer D, Hernandez G. Lactate-guided resuscitation saves lives: we are not sure. Intensive Care Med. 2016;42(3):472–4.
Ding XF, Yang ZY, Xu ZT, et al. Early goal-directed and lactate-guided therapy in adult patients with severe sepsis and septic shock: a meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):331.
Bakker J, Postelnicu R, Mukherjee V. Lactate: where are we now? Crit Care Clin. 2020;36(1):115–24.
Ronflé R, Lefebvre L, Duclos G, et al. Venous-to-arterial carbon dioxide partial pressure difference: predictor of septic patient prognosis depending on central venous oxygen saturation. Shock. 2020;53(6):710–6.
Mallat J, Pepy F, Lemyze M, et al. Central venous-to-arterial carbon dioxide partial pressure difference in early resuscitation from septic shock: a prospective observational study. Eur J Anaesthesiol. 2014;31(7):371–80.
Ospina-Tascón GA, Bautista-Rincón DF, Umaña M, et al. Persistently high venous-to-arterial carbon dioxide differences during early resuscitation are associated with poor outcomes in septic shock. Crit Care. 2013;17(6):R294.
Gårdlund B, Dmitrieva NO, Pieper CF, Finfer S, Marshall JC, Taylor TB. Six subphenotypes in septic shock: latent class analysis of the PROWESS Shock study. J Crit Care. 2018;47:70–9.
Kim WY, Jung JW, Choi JC, Shin JW, Kim JY. Subphenotypes in patients with septic shock receiving vitamin C, hydrocortisone, and thiamine: a retrospective cohort analysis. Nutrients. 2019;11(12):2976.
Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003–17.
László I, Trásy D, Molnár Z, Fazakas J. Sepsis: from pathophysiology to individualized patient care. J Immunol Res. 2015;2015:510436.
Toulouse E, Masseguin C, Lafont B, et al. French legal approach to clinical research. Anaesth Crit Care Pain Med. 2018;37(6):607–14.
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10.
Leone M, Constantin JM, Dahyot-Fizelier C, et al. French intensive care unit organisation. Anaesth Crit Care Pain Med. 2018;37(6):625–7.
Gall JRL, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.
Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure: on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine (see contributors to the project in the appendix). Intensive Care Med. 1996;22(7):707–10.
Martin C, Medam S, Antonini F, et al. Norepinephrine: not too much, too long. Shock. 2015;44(4):305–9.
Gu WJ, Zhang Z, Bakker J. Early lactate clearance-guided therapy in patients with sepsis: a meta-analysis with trial sequential analysis of randomized controlled trials. Intensive Care Med. 2015;41(10):1862–3.
Guarracino F, Bertini P, Pinsky MR. Cardiovascular determinants of resuscitation from sepsis and septic shock. Crit Care. 2019;23(1):118.
Lamontagne F, Day AG, Meade MO, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018;44(1):12–21.
Ip EH, Zhang Q, Schwartz R, et al. Multi-profile hidden Markov model for mood, dietary intake, and physical activity in an intervention study of childhood obesity. Stat Med. 2013;32(19):3314–31.
Ip EH, Zhang Q, Rejeski WJ, Harris TB, Kritchevsky S. Partially ordered mixed hidden Markov model for the disablement process of older adults. J Am Stat Assoc. 2013;108(502):370–80.
Rabiner LR. A tutorial on hidden Markov models and selected applications in speech recognition. Proc IEEE. 1989;77(2):257–86.
Rejeski WJ, Ip EH, Bertoni AG, et al. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med. 2012;366(13):1209–17.
Avis NE, Levine B, Marshall SA, Ip EH. Longitudinal examination of symptom profiles among breast cancer survivors. J Pain Symptom Manage. 2017;53(4):703–10.
Ip EH, Saldana S, Arcury TA, Grzywacz JG, Trejo G, Quandt SA. Profiles of food security for US farmworker households and factors related to dynamic of change. Am J Public Health. 2015;105(10):e42-47.
Asfar P, Teboul JL, Radermacher P. High versus low blood-pressure target in septic shock. N Engl J Med. 2014;371(3):283–4.
Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-Day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323(10):938–49.
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–77.
Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42(9):1387–97.
Casserly B, Phillips GS, Schorr C, et al. Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database. Crit Care Med. 2015;43(3):567–73.
Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007;33(11):1892–9.
Ospina-Tascón GA, Umaña M, Bermúdez W, et al. Combination of arterial lactate levels and venous-arterial CO2 to arterial-venous O2 content difference ratio as markers of resuscitation in patients with septic shock. Intensive Care Med. 2015;41(5):796–805.
Vallée F, Vallet B, Mathe O, et al. Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock? Intensive Care Med. 2008;34(12):2218–25.
Gårdlund B, Dmitrieva NO, Pieper CF, Finfer S, Marshall JC, Taylor TB. Six subphenotypes in septic shock: latent class analysis of the PROWESS Shock study. J Crit Care. 2018;47:70–9.
Vincent JL. How I treat septic shock. Intensive Care Med. 2018;44(12):2242–4.
Lang E, Neuschwander A, Favé G, et al. Clinical decision support for severe trauma patients: machine learning based definition of a bundle of care for hemorrhagic shock and traumatic brain injury. J Trauma Acute Care Surg. 2022;92(1):135–43.
Acknowledgements
The authors are indebted to the nursing staff of the polyvalent intensive care units for providing the best care to their patients. We thank all the participants of the study.
Funding
No funding or sponsorship was received for this study or publication of this article.
Author Contributions
Alexandre Cereuil: Concept, design and drafting the manuscript. Romain Ronflé: Concept, design and drafting the manuscript. Aurélien Culver: Reviewing. Mohamed Boucekine: statistical analysis. Laurent Papazian: Reviewing. Laurent Lefebvre: Reviewing. Marc Leone: Concept, design and reviewing the manuscript.
Compliance with Ethics Guidelines
The initial study was approved by the ethics committee of Nice University Hospital, France (Agreement number 2016-A00533-48). The ancillary study was also approved by the ethics committee of the French Society of Anaesthesia, Critical Care and Perioperative Medicine (SFAR), (Agreement number IRB 00010254-2022-078) and their opinion covers multiple hospitals. The requirement for written informed consent was waived because of this study’s strict observational design, according to French law [29]. However, we obtained the patient’s or relatives’ consent to use these data.
Disclosures
All the authors have nothing to disclose.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cereuil, A., Ronflé, R., Culver, A. et al. Septic Shock: Phenotypes and Outcomes. Adv Ther 39, 5058–5071 (2022). https://doi.org/10.1007/s12325-022-02280-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-022-02280-5